Abbott Completes Enrollment of Absorb Randomized Clinical Trials in the United States, Japan and China

By: via Benzinga
Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.